ORIGINAL RESEARCH article
Front. Vet. Sci.
Sec. Animal Reproduction - Theriogenology
Volume 12 - 2025 | doi: 10.3389/fvets.2025.1608791
This article is part of the Research TopicEndometrial Health and Disease: From Molecular Insights to Clinical AdvancesView all articles
Evaluation of Lactiplantibacillus plantarum CRS 33 to therapeutic effects on a murine model of E. coli-induced endometritis
Provisionally accepted- 1College of Animal Science and Technology, Agricultural University of Hebei, Baoding, Hebei Province, China
- 2Key Laboratory of Healthy Breeding in dairy cattle (Co-construction by Ministry and Province), Ministry of Agriculture and Rural Affairs, Hebei Agricultural University, Baoding, China, Baoding, China
- 3College of Veterinary Medicine, Hebei Agricultural University, Bao Ding, China, Baoding, China
- 4Center of Microbiology, Veterinary Research Institute, Peshawar, Peshawar, Khyber Pakhtunkhwa, Pakistan
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Bovine endometritis, common in postpartum dairy cows, is traditionally treated with antibiotics. However, antibiotic usage is associated with the induction of antimicrobial resistance and treatment failure. Lactiplantibacillus plantarum CRS33 is a newly identified probiotic with strong anti-bacterial activity isolated from a healthy cow uterus in our laboratory. This study sought to explore the probiotic potential of Lactiplantibacillus plantarum CRS33 through whole-genome sequence analysis and evaluate its anti-inflammatory effects on experimentally induced endometritis in mice caused by Escherichia coli (E. coli). A treatment dose of Lactiplantibacillus plantarum CRS33 (1×109 CFU/mL) was selected for endometritis therapy in mice. Whole-genome sequencing results showed that the strain possesses genes associated with antibacterial, anti-inflammatory, and immune-regulating pathways, while no drug resistance or pathogenicity genes were identified. Lactiplantibacillus plantarum CRS33 significantly reduced endometrial inflammation, inhibiting pathological changes and reducing uterus wet weight index (p < 0.05). It also suppressed inflammatory cell infiltration and reduced pro-inflammatory cytokine levels (IL-6, IL-1β, IL-8, TNF-α). Furthermore, Lactiplantibacillus plantarum CRS33 diversifies the microbial community and increases the proportion of dominant flora in the uterus. Although these findings highlight the potential of probiotics in treating bovine endometritis, this study is limited by the use of a mouse model. We will consider further validation in dairy cows.
Keywords: Lactiplantibacillus plantarum CRS33, Escherichia coli, Whole genome, Inflammatory factors, Bovine endometritis, Probiotic therapy, microbiome, murine model
Received: 02 May 2025; Accepted: 13 Oct 2025.
Copyright: © 2025 Liu, Wen, Feng, Sun, Feng, Jin, Liu, Muhammad, Liu, Cheng and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Jia Cheng, chengjia@hebau.edu.cn
Jianguo Li, jgli@hebau.edu.cn
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.